Clinical Trial Update: The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries [NA]

View source ↗

Summary

This entry reports a clinical trial comparing the Elixir Bioadaptor versus the Onyx stent for de novo native coronary arteries, with results posted on 2024-10-2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Stenosis

Drugs mentioned

• Elixir Bioadaptor
• Onyx Stent

Snippet

Sponsor: Elixir Medical Corporation | Conditions: Coronary Artery Disease, Coronary Artery Stenosis | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-10-22